Search research articles
Contact Us
Filters
Showing results (71-80 of 76) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 76 results.
The Lancet. Respiratory Medicine
|
November 9, 2025
A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders
Athol U Wells, Elyse E Lower, Robert P Baughman, et al.
JAMA Network Open
|
August 8, 2019
Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis
Sachin Yende, John A Kellum, Victor B Talisa, et al.
Critical Care Medicine
|
February 13, 2019
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)
Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Intensive Care Medicine
|
October 3, 2019
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
March 22, 2020
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
Franck F Rahaghi, Robert P Baughman, Lesley Ann Saketkoo, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 16, 2020
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
Elliott D Crouser, Lisa A Maier, Kevin C Wilson, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 76) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 76 results.
The Lancet. Respiratory Medicine
|
November 9, 2025
A paradigm shift in corticosteroid therapy for sarcoidosis: a World Association of Sarcoidosis and Other Granulomatous Disorders Position Paper, endorsed by the Americas Association of Sarcoidosis and Other Granulomatous Disorders
Athol U Wells, Elyse E Lower, Robert P Baughman, et al.
JAMA Network Open
|
August 8, 2019
Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis
Sachin Yende, John A Kellum, Victor B Talisa, et al.
Critical Care Medicine
|
February 13, 2019
Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)
Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
Intensive Care Medicine
|
October 3, 2019
Immune checkpoint inhibition in sepsis: a Phase 1b randomized study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of nivolumab
Richard S Hotchkiss, Elizabeth Colston, Sachin Yende, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
March 22, 2020
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
Franck F Rahaghi, Robert P Baughman, Lesley Ann Saketkoo, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 16, 2020
Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline
Elliott D Crouser, Lisa A Maier, Kevin C Wilson, et al.
Page
of 8